Unipi Team Leader: Prof. Massimo Pasqualetti, Dipartimento di Biologia 

Many neuropsychiatric disorders are treated using drugs that target the transmission of the neurotransmitter serotonin. However, the suboptimal efficacy of these drugs alongside new lines of research highlighting a role for serotonin in neurodevelopment have urged scientists to revisit the origins and treatment of these disorders.

The EU-funded SEROTONIN and BEYOND project will work under the hypothesis that serotonin-related neuropsychiatric disorders are caused by neurodevelopmental changes. To address this scientific concept, the project will train early-stage researchers in state-of-the-art techniques, preparing them for a bright career in the field.

Coordinator

STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM, Netherlands

Other participants

• UNIVERSITA DI PISA, Italy
• INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE, France
• UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT, Germany
• MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC), Germany
• PHILIPPS UNIVERSITAET MARBURG, Germany
• EUROPEAN MOLECULAR BIOLOGY LABORATORY, Germany
• ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM, Netherlands
• THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD, United Kingdom
• REGION HOVEDSTADEN, Denmark
• METRIS BV, Netherlands
• STICHTING RADBOUD UNIVERSITEIT, Netherlands

Start date: 1 January 2021
End date: 31 December 2024
Project cost: € 4 012 551
Project funding: € 4 012 551
Unipi quota: € 261 499,68
Call title: H2020-MSCA-ITN-2020
Unipi role: Partner
Project website: https://www.serotonin-and-beyond-project.eu/